A new research paper was published by Aging (Aging-US) on January 6, 2025, in Volume 17, Issue 1, titled "The profile of ...

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow ...

Finasteride is used to treat benign prostatic hyperplasia. For a very few men, this causes pain in the breast tissue.

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ...

By Temitope PonleDr Sam Adegboye, a Physician, has debunked the claim that frequent sexual activity reduces the risk of prostate cancer in men.Adegboye is the Assistant Chief Medical Officer and ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ...

Our research results suggest that pro-inflammatory mediators and suppressors of inflammation are involved in the development ...

Alpha-1 adrenergic antagonists produce greater improvement in voiding symptoms and urinary flow rates than finasteride alone. No additive or synergistic effects have been proven when terazosin was ...